Videos – Rosacea

Guy Webster, MD, PhD, AARS Honorary Chair, with Distinction, talks about the most promising developments in acne care, the treatment pipeline, advancements for rosacea, and more. He even addresses why some people develop acne and rosacea, while others do not.

0 0

To get the best out of a dermatology appointment for acne, rosacea, or HS come prepared to answer a lot of questions from your dermatologists. And be ready to ask questions of your own. Clear communication is key to care, says Diane Thiboutot, MD, Past President of the American Acne and Rosacea Society.

0 0

Diane Thiboutot, MD, Past President of the American Acne and Rosacea Society, explores the role of the microbiome in skin disease and assesses the potential to treat acne through microbiome management.

0 0

Rosacea is an inflammatory skin disease that affects millions of Americans, producing pimples, papules, and background redness. Newer treatments offer hope, but there is need for more drug development. Get an update from Diane Thiboutot, MD, Past President of the American Acne and Rosacea Society.

0 0

Hilary Baldwin, MD
Dermatologist and AARS Past President, says that many patients with rosacea don’t recognize the symptoms of the disease. They may seek treatment for other skin concerns or a specific rosacea symptom without recognizing other aspects of the condition. She describes common symptoms like flushing and blushing, gritty or dry eye, and swelling of the nose.

0 0

Prevalence of Rosacea in Transgender and Gender Diverse Populations: A Retrospective Cohort Study, Jessika Sanz, BS

Hormone modulating treatments, like oral contraceptive pills, estrogen replacement therapy, and spironolactone, have been shown to improve symptoms of rosacea. Researchers questioned the effect of gender-affirming hormone therapy on the incidence of in transgender and gender diverse patients. Jessika Sanz, BS, of the NYIT College of Osteopathic Medicine, and colleagues explored the incidence of rosacea in transgender patients compared to cis-gender patients. Their findings suggest that feminizing gender-affirming hormone therapy may be associated with a reduced incidence of rosacea, while masculinizing gender-affirming hormone therapy did not seem to effect incidence of rosacea. Discussion focuses on findings and implications for care and future research.

1 0

Topical Irvermectin Modulates the Skin Microbiome and Improves Symptoms of Rosacea, Joyce Cheng, MD, MHS

Topical ivermectin is recognized as an effective treatment FDA-approved for the management of rosacea. It has been shown to decrease Demodex and reduce inflammation. Given the role of dysbiosis in rosacea, researchers questioned the potential impact of topical ivermectin on the skin microbiome. Joyce Cheng, MD, MHS, of the Department of Dermatology at the University of San Diego, and colleagues explored the effects of topical ivermectin on the microbiome of patients with rosacea. They found that topical application was associated with an increase in S. epidermidis in lesional and non-lesional skin, an increase in C. acnes in lesional skin, and a decrease in Demodex in lesional and non-lesional skin.

27 0

Hester Gail Lim, MD presents at the 6th Annual AARS Symposium.

Full Title: Rosacea Associated with Increased Prevalence of Gastrointestinal Disorders in Absence of Systemic Antibiotics

See the AARS website for more presentations: https://acneandrosacea.org/initiatives/scientific-symposia/6th-annual

89 0

Noori Kim, MD presents at the 6th Annual AARS Symposium.

Full Title: Increased CAMP and KLK5 Expression in Conjunctival Epithelium Associated with Ocular Rosacea Severity

See the AARS website for more presentations: https://acneandrosacea.org/initiatives/scientific-symposia/6th-annual

3 0